Emilia Maggio1, Antonio Polito2, Guido Prigione2, Grazia Pertile2. 1. Department of Ophthalmology, Ospedale S. Cuore - Don Calabria, Via Don Sempreboni,5, Negrar, 37024, Verona, Italy. emi_maggio@yahoo.it. 2. Department of Ophthalmology, Ospedale S. Cuore - Don Calabria, Via Don Sempreboni,5, Negrar, 37024, Verona, Italy.
Abstract
PURPOSE: To describe the clinical findings and management of eyes affected by uveal effusion syndrome (UES) presenting with clinical features mimicking inflammatory ocular diseases, treated using individualized surgical approaches. METHODS: We report a consecutive interventional case series of seven eyes of four patients affected by UES. On presentation in our clinic, all patients showed signs of steroid effects as a consequence of a presumptive diagnosis; one eye had undergone vitrectomy for retinal detachment (RD), without benefit. Diagnosis of UES was based on ophthalmic examination, ultrasonography, fluorescein angiography, biometry and magnetic resonance imaging. Five eyes with active disease were treated using scleral thinning surgical procedures based on the extent and characteristics of the disease: sclerectomy sites were ultrasound-guided to the area of maximal choroidal swelling, associated with evacuative puncture in the case of bilateral funnel-shaped RD. RESULTS: One patient was diagnosed with type 1 UES, two with type 2, and one with type 3. Mean postoperative follow-up was 26 months. In all eyes, surgery resolved the ciliochoroidal and retinal detachment and improved visual acuity. In two eyes, visual restoration was limited by a prolonged disease course. CONCLUSION: UES may be mistaken for other sources of ciliochoroidal effusion. Early diagnosis and treatment is critical to avoid unnecessary procedures and to prevent severe visual loss as a result of neuroretinal damage. Surgical treatment based on the extent and characteristics of the disease may be effective for the resolution of ciliochoroidal effusion, even in type 3 UES, where conventional surgery has proved unsuccessful.
PURPOSE: To describe the clinical findings and management of eyes affected by uveal effusion syndrome (UES) presenting with clinical features mimicking inflammatory ocular diseases, treated using individualized surgical approaches. METHODS: We report a consecutive interventional case series of seven eyes of four patients affected by UES. On presentation in our clinic, all patients showed signs of steroid effects as a consequence of a presumptive diagnosis; one eye had undergone vitrectomy for retinal detachment (RD), without benefit. Diagnosis of UES was based on ophthalmic examination, ultrasonography, fluorescein angiography, biometry and magnetic resonance imaging. Five eyes with active disease were treated using scleral thinning surgical procedures based on the extent and characteristics of the disease: sclerectomy sites were ultrasound-guided to the area of maximal choroidal swelling, associated with evacuative puncture in the case of bilateral funnel-shaped RD. RESULTS: One patient was diagnosed with type 1 UES, two with type 2, and one with type 3. Mean postoperative follow-up was 26 months. In all eyes, surgery resolved the ciliochoroidal and retinal detachment and improved visual acuity. In two eyes, visual restoration was limited by a prolonged disease course. CONCLUSION: UES may be mistaken for other sources of ciliochoroidal effusion. Early diagnosis and treatment is critical to avoid unnecessary procedures and to prevent severe visual loss as a result of neuroretinal damage. Surgical treatment based on the extent and characteristics of the disease may be effective for the resolution of ciliochoroidal effusion, even in type 3 UES, where conventional surgery has proved unsuccessful.
Authors: Timothy L Jackson; Ali Hussain; Ana M S Morley; Paul M Sullivan; Andrea Hodgetts; Austen El-Osta; Jost Hillenkamp; Stephen J Charles; Richard Sheard; Tom H Williamson; Anupma Kumar; D Alistair H Laidlaw; W Hong Woon; Mark J Costen; Andrew J Luff; John Marshall Journal: Invest Ophthalmol Vis Sci Date: 2008-06-14 Impact factor: 4.799
Authors: M Uyama; K Takahashi; J Kozaki; N Tagami; Y Takada; H Ohkuma; H Matsunaga; T Kimoto; T Nishimura Journal: Ophthalmology Date: 2000-03 Impact factor: 12.079
Authors: Silvana Vianello; Gláucio Silva de Souza; Maurício Maia; Rubens Belfort; João Rafael de Oliveira Dias Journal: JAMA Ophthalmol Date: 2019-03-01 Impact factor: 7.389